The biggest point of confusion heading into 2026 involves the Special Authorization that Puerto Rico's Department of Health imposed on non-resident wholesalers and virtual manufacturers back in 2022 and 2023. Reports indicate this requirement was repealed in mid-2025. That repeal, however, doesn't wipe out every other obligation tied to doing business in Puerto Rico.
This guide walks through entity classification, registration requirements, documentation, application sequencing, and ongoing compliance. Verify every detail against current Puerto Rico Department of Health and SARSP (Secretaría Auxiliar para la Regulación de la Salud Pública) materials before shipping anything into the territory.
Key Takeaways
- Confirm with SARSP whether the 2022 Special Authorization for non-resident wholesalers was rescinded in June 2025.
- Budget for State Department and Hacienda registrations in addition to drug-specific licensing.
- Treat Regulation 156B product registration as separate from FDA approval; controlled substances add extra duties.
- Map your license path by entity type: manufacturer, wholesaler, virtual, 3PL, pharmacy, or device/combination.
What Changed for Non-Resident Wholesale Drug Distributors in Puerto Rico?
In 2022, Puerto Rico's Department of Health introduced a Special Authorization requirement specifically targeting non-resident wholesale distributors and manufacturers. The agency reinforced this in March 2023 with Administrative Order 564 (OA 564), which extended the authorization concept to virtual manufacturers and virtual distributors (companies that never physically touch the product they're buying or selling).
Articles written between 2022 and early 2025 describe this authorization as mandatory. Many of them are still indexed and widely cited. That's the problem: they describe a rule that may no longer be in effect.
The June 2025 Repeal
On June 17, 2025, the Department of Health issued Administrative Order 612 (OA 612), repealing OA 564's Special Authorization for virtual manufacturers and virtual distributors, effective immediately.
According to a legal alert from McConnell Valdés published June 23, 2025, a separate letter dated the same day rescinded the original 2022 notice that applied to non-resident wholesalers more broadly.
These are two distinct actions, not one blanket repeal. Before that, in March 2025, SARSP had actually given non-resident wholesalers a fresh 90-day window to submit Special Authorization applications, so the repeal arrived just months after the agency reaffirmed the requirement.
Old rule versus current position:
| Aspect | Pre-June 2025 | Reported Current Position |
|---|---|---|
| Virtual manufacturers/distributors | Special Authorization required (OA 564, March 2023) | Repealed by OA 612, effective June 17, 2025 |
| Non-resident wholesale distributors | Special Authorization required (2022 notice); deadline extended March 2025 | Reportedly rescinded by separate June 17, 2025 letter |
| Product registration (Regulation 156B) | Required | Unaffected; still required |
| Business/tax registration | Required | Unaffected; still required |
If your company has a pending, active, or previously approved Special Authorization, don't assume what happens next. Contact SARSP directly about any replacement filing, transitional notice, or portal requirement for your situation.
A repeal of one authorization does not drop these separate obligations:
- Business and tax registration
- Product registration under Regulation 156B
- Controlled-substance rules under their own statutes
Puerto Rico Requirements by Business Model and Product Type
Your obligations depend heavily on what kind of entity you are and what you're shipping. A virtual distributor, a physical manufacturer, and a pharmacy filling remote prescriptions all sit under different rules.
Baseline Requirements for Non-Resident Wholesalers
Every non-resident wholesale distributor needs to maintain its licensing status in its home jurisdiction first. Puerto Rico's own Pharmacy Act 247 addresses licensing of wholesale distributors and restricts distribution to authorized, registered establishments.
Confirm with SARSP whether proof of your home-jurisdiction license is still required for submission. Repeal of the Special Authorization does not automatically drop that underlying expectation.
Business and Tax Registration
Two separate Puerto Rico government bodies may require filings:
- Puerto Rico State Department: foreign corporations operating in Puerto Rico generally need authorization to do business, along with a recent certificate of existence from their home jurisdiction and resident-agent details.
- Hacienda (Treasury Department): new merchants register through the SURI online system for tax purposes.
Neither agency's published guidance specifically confirms that every shipment from outside Puerto Rico triggers both registrations automatically. This depends on physical presence, personnel, and the nature of your sales activity. Verify your specific fact pattern with each agency.
Drug and Product Registration
Regulation 156B requires Puerto Rico-specific registration of medicines, even those already FDA-approved. A licensed manufacturer, distributor, or a notified representative agent can file this registration. The submission typically includes:
- Manufacturing/preparation facility address and contact details
- Puerto Rico distributor information
- FDA approval status and NDC number
- Representative agent designation, where applicable
As a wholesale distributor, confirm who in your supply chain is actually responsible for this filing and keep documentation proving it's been completed.
Controlled Substances
Puerto Rico's Controlled Substances Act (Act 4) requires separate Health Secretary registration for covered manufacture, distribution, or dispensing activity in the territory. That local registration is in addition to your DEA registration, not a substitute for it. Storage security, recordkeeping, and inventory rules apply locally too.
Business Model Variations
| Model | Key Distinction |
|---|---|
| Virtual manufacturer/distributor | Special Authorization repealed under OA 612; product registration still applies |
| Physical manufacturer/3PL | Act 247 governs manufacturing/wholesale operations; no confirmed blanket 3PL license category |
| Pharmacy dispensing | Separate license framework under Act 247; prescription-based shipments aren't automatically "non-wholesale" |
| Devices, supplements, veterinary products | Each category has its own registration track under Regulation 156B |
Pharmacy shipments made under a valid prescription aren't automatically treated the same as wholesale distribution — classification depends on the actual transaction structure, not just the presence of a prescription somewhere in the chain. Get SARSP's position on your specific model before assuming either way.
How to Apply: Documents, Sequence, and Verification Steps
Start by mapping your actual business model before touching any application form.
Step 1: Define Your Operation
Answer these questions first:
- Are you selling directly into Puerto Rico, or providing logistics/storage services for someone else's product?
- Who holds title to the product at each stage of the shipment?
- Does your company physically touch the product, or does it operate as a virtual distributor?
- Are any products controlled substances requiring additional registration?
Step 2: Build Your Document File
A thorough compliance file typically includes:
- Formation and corporate existence documents
- Home-jurisdiction wholesale or manufacturer license
- FDA documentation (approval letters, NDC listings)
- DEA registration, where controlled substances are involved
- Product labels and package inserts
- Responsible-person and facility details
- Representative agent designation (if using one)
Step 3: Confirm Product Eligibility
Before any shipment leaves your warehouse, verify:
- Current Puerto Rico registration status for the specific product
- NDC number accuracy and label-holder responsibility
- Prescription versus OTC classification
- Whether the product carries a controlled-substance designation
Step 4: Research Current Portals and Procedures
SARSP's historical application process used an online renewal portal with self-certification and bond documents. That process was tied to the Special Authorization that has reportedly been rescinded. Don't assume that portal still applies to a 2026 filing. Confirm current forms, fees, payment methods, and notarization requirements directly with the agency before submitting anything.
Pre-Submission Quality Control Checklist
Run through this before filing:
- Legal names and addresses match exactly across every document
- Labels are complete and match registered product information
- Agency and representative contact information is current
- Home-jurisdiction licenses aren't expired or about to lapse
- Controlled-substance materials are complete, if applicable
- Copies of every submission and approval are retained in your compliance file
Companies expanding into regulated markets often outsource entity formation and tax registration (State Department filing, Hacienda/SURI registration, and accurate corporate records) to a firm that handles cross-border setup regularly.
VJM Global supports businesses entering new jurisdictions on entity formation and tax compliance, while specialized Puerto Rico health counsel handles the drug-specific licensing work. Splitting these workstreams keeps each piece with the right specialist.
Ongoing Compliance, Renewals, Inspections, and Risks
Approval only starts the obligation. Puerto Rico expects continuing compliance after registration.
Recurring obligations include:
- Renew registrations where applicable — Regulation 156B authorizes initial product registration for two years, then one-year renewals
- Updating records when legal name, address, label holder, or representative agent changes
- Maintaining distribution, storage, and handling records consistent with Act 247
- Reporting recalls and verifying removal orders through your representative agent
What Triggers Agency Review
Inspections and reviews can stem from facility access requests, recordkeeping audits, distribution history checks, recalls, or suspicious order patterns. Controlled-substance operations face additional scrutiny under Act 4, including secure storage requirements and inventory accuracy checks.
No confirmed 2026 notice sets a fixed reporting interval or a standard temperature-control specification for cold-chain products. Verify those specifics directly with SARSP for your product category.
Risks of Non-Compliance
Act 247 includes administrative fine provisions and allows license suspension for nonpayment or violations. Act 4 permits suspension or revocation of controlled-substance registration for cause.
Specific penalty amounts, seizure procedures, and criminal exposure thresholds for unlicensed non-resident shipments are not clearly set out in available agency materials. Do not assume a penalty figure without confirming it directly. Treat every enforcement risk as a reason to verify your status before shipping, not after.
Common Mistakes That Delay or Jeopardize Market Entry
A surprising number of companies still cite outdated guidance. Here's where things typically go wrong:
- Relying on pre-June 2025 articles that describe the Special Authorization as active, without checking current SARSP or Department of Health notices
- Submitting incomplete product packages: missing FDA documentation, absent NDC numbers, or inconsistent labeling
- Letting home-jurisdiction licenses expire mid-application, which can stall the entire file
- Misclassifying products, particularly combination products or borderline device/drug items
- Omitting representative agent information required for product registration
- Forgetting separate controlled-substance registration, assuming DEA registration alone covers Puerto Rico
The fix for most of these issues is a simple tracking system. Build a compliance calendar that logs every registration, renewal date, agency notice, product change, and responsible-party update.
Companies that treat Puerto Rico entry as a one-time filing exercise tend to get caught off guard by renewal deadlines or ownership changes they forgot to report. A calendar approach, paired with a firm that already tracks multi-jurisdiction compliance deadlines for a living, closes that gap before it becomes a problem.
Frequently Asked Questions
Can US pharmacies fill prescriptions from Puerto Rico?
This depends on whether the transaction counts as dispensing a valid prescription or wholesale distribution. Those paths are regulated differently. Verify applicable federal, state, Puerto Rico, and pharmacy-practice rules for your specific transaction before proceeding.
How do I get a business license in Puerto Rico?
The process depends on your entity type and activity. You'll likely need Puerto Rico Department of State authorization, Hacienda tax registration, and any Department of Health industry-specific licensing that applies to your business.
Does Puerto Rico still require a Special Authorization for non-resident wholesale drug distributors in 2026?
Reports indicate the 2022 Special Authorization requirement was rescinded via a June 2025 letter, separate from OA 612's repeal for virtual entities. Confirm the current position and any replacement filing directly with SARSP before shipping.
Do wholesale drug distributors need to register products in Puerto Rico?
Manufacturers or label holders typically register products under Regulation 156B, but distributors should still verify that registration is complete and current. Check product-specific rules before any sale or distribution.
Is FDA approval enough to distribute a drug in Puerto Rico?
No. FDA approval doesn't replace Puerto Rico's business registration, product registration, or controlled-substance requirements. These sit under separate territorial statutes that apply regardless of federal status.
Does a controlled substance require additional registration in Puerto Rico?
Yes. Puerto Rico's Controlled Substances Act requires local Health Secretary registration alongside your DEA registration. Confirm the exact filing obligations for your company, product, and local arrangements before distributing.
